<DOC>
	<DOC>NCT02665390</DOC>
	<brief_summary>This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.</brief_summary>
	<brief_title>Percutaneous Cryoablation Peripheral Lung Cancer</brief_title>
	<detailed_description>The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>medically inoperable peripheral lung cancer Diameter no more than 3cm 1. Refusal of participation 2. tendency to bleed to that can't receive percutaneous cryoablation. 3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>Percutaneous cryoablation</keyword>
	<keyword>treatment of medically inoperable</keyword>
</DOC>